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prior to and after injury {' 540 ~: 311. 1658 • 493). The aorta was fixed and 
Immunohlsto~homistry was performed for VN and ~vv/~3, 
Results: in Group t. VN was detected ss esrly aa 1 day. with peak levels 
at 3 days and lower levels at 6 weeks. VN was primarily localized along the 
lumen nt the earlier time points (suggesting deposition) and in the neolntima 
nnd media st the later time points (suggesting synthesis), The time course 
end distribution of ,~vtl3 was needy Identical to VN. In Groups II and IlL the 
Accumulation of VN nnd ~vtl3 was augmented and especially In the noolnttma. 
Conclusion: We conclude that VN end ~v/~3 are detected early after 
balloon IflJttry, consistent with rotes in Ifltlmel hyperplAsl~, Notably, hypem. 
hola~terolomls markedly accentuated the ooo~mulatlon of VN and,vp3 after 
b~tlcon Injury, euggestlng s novel mechanism I~y which hypAmholeMerolemln 
may Contflbute 1o the progression of etharo~lero~ls and restenosia. 
~ Human MOP.1 Is In Reetenotlo Upmgulsted 
Lesions When Compared With de Nova Lesions. 
In Vlv~ and In Vitro Study 
M,M, Rozak, R, Wojntcz, C, ChAng, A,J, Neder, ~,R, Klas~, University at 
~x/~ HSC ~f S~n Antont~, USA 
We reported previously the pm~en~e at monoeyte ohemoattrat~t~nt protein.1 
(MOP,l) gane In human eorene~/ srt0rieel, To determine whether MCP,I 
is involved In the restenosls we examined MCP,1 e~presston by immuno- 
oytochemistry in stherectomy ~peelmans and In smooth muscle cell (SMC) 
cultures derived from de nova (N) And rest0n0tto (R) eorenAry athemmas, 
Tissue wa~ obtained from 37 pntlanla (28 wide novo emd 12 w/rosmnotic 
leslqnA), MCP-1 mRNA levels were anAty~'ed by Nodham Blots before (OD 
units) and after challenge with TNF,~, PDGF, IGF.1 and An~lotonsin II (All) 
from 30 rain, to 96 hours (%change over unetlmulated control), MCP-1 was 
also mess(lred In condllloned medls by RIA, 
Rasu~: MCP,1 levels wore higher In restenosls thnn Id De nova lesions 
In SMC 0uttures: 136,5 ~ 38,B ODU vs, ~7g,6 ~ 67.30DU (p < 0,002), re. 
speotlvety, After the challenge MCP,1 mRNA lav~ls in N Increased as follows: 
TNF¢~ by 226,4 :E 32,6% POGF by 182.6 st: 25,2%. IGF-1 by 176,2 ..t: 21,3% 
All by 186.5 • 23,2% (~11 p < 4,001 ), In R MCP-1 levels did not changed after 
the challenge: 23,2 -t- 23,1%, 13,4 ~, f 2,g%, 16,4 :~ 2f ,4%, and 8,6 • 12,6%, 
respectively (all N$), Analysis el MCP-1 in the Conditioned medium revealed: 
N SMCc 5.6 st: 2,1 ng/t0 ~ cells, R lesions 22.3 ~ 5,2 ng (p -.. 0,01), After the 
challenge: N SMCc TNF~ 18.,5 -~ 6.4 null0 ~ cells, PDGF 16.6 ~ 5.4 ng/10 ~ 
ceils, tGF.1 14,9 st- 5.4 null03 cells and All 12,5 ± 3,3 ng/lO ~ cells (all p < 
0,001), In R lesions: 26,6 st- 3.2 ngfl0 ~ ceils 24,6 ~ 4,1 null0 ~ celts, 19.S ± 
3,2 ng/10 ~ cells and 21,2 ± 4.2 ng/10 '~ cells, respectively (NS). 
Conclusions: Both, in viva and in vitro study suggests that MCP-1 is 
s~gntficanfly greater m restenotlc ff~an in de nova 6theremas. In addition. 
MCP-1 geno in do nova lesions can bo upregulated with PDGF, TNF(~, IGF-1 
nnd Angtotenstn II MCP- 1 appears to be maximally upregulated in restenotic 
lesions, An important nolo for the MCP-1 protein in the restenosis process is 
implied. 
• Apoptos l$  end Cell PrOliferation Fol lowing 
Porcine Angloplaaty 
N, Mallk, S,E, Francis, C,M. Holt, J, Gunn, L, Shepherd, CM,H Newman. 
D.C, Cumberland, D.C, Cressman, Universlly of Sheffield, UK 
Background: Angtoplasty initiates a number of responses in the vessel wall, 
including cellular proliferation, which contdbute to noolntima formation and 
restenosls. Cellular homeostasis within a tissue depends on the balance 
between cell proliferation and apoptosis. The profiles of apoptosis and pro- 
day time period. 
MethOds: 42 arteries from 21 pigs, harvested at the site of maximal injury 
at 1. 6, 18 hours and 3, 7, 14 and 28 days post,PTCA (n = 3 animals 
per timepoint), using the uninjured arteries as controls, were examined. 
Apoptosls was demonstrated by TUNEL, TEM and DNA fragmentation, and 
cells traversing the cell-cycle were identified by immunostaining for PCNA, 
Results: Apoptosis was not detected in control vessels nor at 2~ days 
post-PTCA. Apoptotic cells were identified at early timepoints with a peak at 
6 h (5.1 :E 0,26%; compared to uninjured artery p < 0.001 ) and confirmed by 
characteristic DNA ladders and TEM findings, in comparison, PCNA staining 
peaked at 3 d~ys post PTCA (7.16 :~ 0.29 ,;,, compared to uninjured artery p 
< 0,005). The prefi;es of apoptosis and celt proliferation post-PTCA differed 
between traumatized and non-traumatized regions of the arterial wall. TEM 
and Immunostaining with cell-type specific markers revealed that the apop- 
totic ceils included VSMCs. inflammatory cells and adventitial fibroblasts. 
Conc/us';ons: The profiles of apoptosis and proliferation following PTCA 
are regionBI and ccll-cpecific and attempts to modulate either of these events 
for therapeutic benefit requires recoqpition of these differences~ 
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Elevated Serum Homocyste lno Is Aosoelstod With 
ExteBt of  Coronary Artery Atheroaelsroals t  
Autopsy 
A, Burke, L, Flnk, A, Faro, R, VtrmanL V~ren~ Aflbim IV~dlc~l G'~n~r, 
Little Rock AR, ~nd the Armed Forces Insfttu~ of Pafho!Og~ W~,~htr~, 
OC, USA 
• lckgroond: Elevation of serum homoo/~tetne has been associated with 
sn increased risk ol venous thrombosis, ~nd, more recently. Acute corermp/ 
events, 
Mefhod~; Hearts from 6"/sudden non<granary ~ths  and t~ eases of 
st~dden e0ronary death (168 men and 6t w~men, mean age ~1 ± 11 years), 
were studied by pedusion hsstian and histnlog~ examination of comna~, 
ertenea, HemocyMelne IAvels warn pedmmed on ix)s_ tmOdem sl~m, 
Resoll~, Coronary thmmbi were noted in 97tl 5~ eases al s~ ~, 'y  
death, By unlvari~te sn~lysls, there WaS no nofmlatlon betwe~t coronary 
death end aemm homoWstelne levels (13.4 .M/L ± 9.8 for controls, 13.1 
8,3 .M/L for sudden coronary death), or between cases with c'omr~ry 
thmmbi ~nd thoe~ without (12,3 ~ 7,5 t*M/L for cases with thmmbi, 13,6 + 
9,5 pM/L for cases without hrombi). The mann % maxima! umir~t nanowm9 
of cases wtth homocystelne >20 I,MIL was 78.6 ~ 21% vs, 65.6% :1:31 fo~ 
those with Ir~mo~ysteine ~_20 #tM/L (p == 0.03), However, by muttivenate 
analy~ts, only elevated ch0lasierel (p ,~ 0,04), diabetes (p = 0.05), and 
ciq.pretle emoklnq.,l~ ,= QD6J showed an asso~iatiort with maximal.cmm~rv 
Conclusion: Homocysteine may be associated with severity of corona W 
atheresclarosts, but not coronary thrombosis or sudden death. 
~ v o n  Wlllebrand Factor .dependent  Shear- induced 
PIMelet Aggroost lon In Acute  Myocmdlat Infarction 
S. Gate, H. Sakai, M. Gate, S. (311o, Y. Ikeda I , S. Hands. Tokai Unitet~ 
Isobars, Japan: W Kem Univetsil),, Tokyo, Japan 
Background: Recent in v/fro studies suggested the crucial role of yen Wills- 
brand factor (vWF) and its interactiou to platelet glycopmteins on platelet 
thrembt~s formation under the effect of bkxx:l flow. We have tested the ,'~f- 
feet of acute myocardial Infamtinn plasma on vWF-dopendent shear-indoc~l 
platalot aggregation 
Mefhoo~: vWF-depeodent shear-induced aggregation el platelets ob- 
tained from normal donors in the presence of plasma from either normal 
donors or fifteen cases el acute myocardial infarction was measured by an 
modified cone-plate viscometer. Antigen levels and hslocetin cofactor ac- 
tivities of vWF as well as plasma indicators of coagulation and fibdnolysis 
including thmmbin anttthrombin III complex (TAT) and plasmlo aeti.plasmm 
complex (PIC) were measured in all enretled plasma. 
Results: vWF.dopeodent shear-induced aggregation of platelets was en- 
hanced by the addition of plasma from acute myocan:liat infarction from 
32.3 :E 10,5% (mean ± SO) to 49.5 ~: 19.8% (p < 0.01), Moreover, acute 
myocardial infarction plasma reduced the threshotd level of shear stress nec- 
essan/to cause vWF-dapendent plaister aggregation from 90 dynes/cr~ to 
72 dynes/ore ~, Fibrtnogen-dependent aggregation occurring under low shear 
stress (12 dynes/ore 2) was not influenced at all by the addition of myOcar- 
be explained by the increase levels of vWF antigen and dstocetin cofactor 
activities as well as relative increase in larger multimers in acute myocardial 
infamtion. 
Conclusion: vWF-dependent shear-reduced platelet aggregation was en- 
hanced in patients with acute myocardial infamtico. This mechanism may be 
relevant to the onset and recurrence of myocardial infarction. 
• Phenotype Characterization of Circulating 
Lympho¢¥~es In Ischemic Heart Disease 
A, Mazzone. S. de $ervi. A. Mussini, L Fossati. J. Mazzucchelli. 
C. Cavalotti. I, Bassi. D, Gntti, G. Ricevuti. Dptoflntemal Medicine & 
Nephro/ogy and Dpt of Cardiology. IRCCS Policlinico S. Matteo Pavia. Italy 
Background: Lymphocytes (LYMPHO) play an important role in the formation 
and evolution of coronary atheroscleretic plaques. The purpose of this study 
was to assess LYMPHO receptors expression in patients (pts) with vadous 
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plasma Iov~ls of tntefleukin (IL) 2, 6 ar¢110, eylokinos which are ablo to affect 
LYMPHO fun~lon and In m0dulato inflammatory proees~u~s, 
Meffmds: Threa groups of pts were studi~: 42 pIS w~m (Idmifted to 
the CCU 13~u~ of on acute lr~tmm~¢ Sy~lrome (AIS group), 36 pie had 
stable ongtna (SA group) and 39 were healthy control subJ(~'ts of equivalent 
age (CTL group), To cl~ra~e~e LYMPHO pbenoM~, flow o/lOmetry was 
pef fO~ in whole, bi0od gmplas ~ l  marx:lanai ~fltibo~te~, IL~, IL.6 
and IL-10 were measured umng ~ ELISA method 
Result" No d ~  was found amtortO lt~e 3 OrO~ l~ the expression 
of C02, C03, CD4, CDa, C019 e~t¢l HLADR m~plom, Double ~nd mple 
ev~ualmn ~t~ an i ~  in C00+C0111~ ~ells (ojlolo=¢ 
T LYMPH<)) a~d in CO16t~O56~COttt~,cetl~ (NK LYMPHO) in tt~ AI$ 
group M~I in ~A OtoUp aS ¢!m~pamd to the CTL group (CD~-CDIlb-*: A!S 
? ~ _2~/~, ~ 0-~ • 1%, c'rL 4,! ± 1%, p ~ 0-05: CDAI~CO~CD!1b*  
AI~ 19,8 :~ 2,3%, SA ~_1.5 ~ !,6%, CTL 6`6 :L 12%, p .~ 0.001), 
W~lhout a~t~tcaity s ~  ~f t~ between A!S at~l SA (;FofllP~- IL-2 
w~ ino, ea~l  in the AtS and SA gn~ aS compared to the CTL group (AIS 
,5.7 ~: O.fl, ~,A 6-5 ± 1.4, CXL ~,4 ± 0,4 pg/ml, p ~ 0.01), whereas Ik.6 WaS 
higher' m tt~ A!S gm~pth#n i  It~ olttm ;~ ~ (AIS 10.8 * 1,?., ~32 ± 
0-,5, CTL ~,0 p ,. 0001). No = t ~  was tour~! between the 3 g ~  m 
the p ~  ~ of !L,t0. 
(~tlCA~:i~tl: These data show II1al ~ wllh ische~ heart disease ha~,e 
an l ~  in eimutalmg cytotot¢ LYMPHO and in IL.2 plasma tewelS as 
~red  Io natural L"(~trOI Stdl~lects. IL'6 =s increased (~ly in pls ~ AIS, 
~ le l tmminuda as a IP~edictor of Coronary  Ar tery  
KR Tuftle, ME. PuNman, S-K. Cooney, LR  Oahtstrm~, T.E. Can~en, 
R~ She~ The Heart Instate at Sp~ane, Spo~t~. Was~mjton, USA 
re,ales to measurable coronan/artery (#rsease (CAD) has not 
been detem~ed. 
/I,~--~=,,~. - In 308 ~ e  patients, u n ~  eleclwe comnaqf on- 
g~:jtald~, alt~mn (RIA) and cma~nine (mo~F~ed JalYe nm) were measured 
m urine lrom an early morning void. The albumin to c,eatimne rafm (ACR) 
wa~ calculated. Fasting plasma msulth (RIA) was n'~asured. Seventy of CAD 
was delemdned by standard ang~jraphtc m~a 
ResuP~: 11~ ACR was 28 ~ 5 in patiertts wffh CAD (n = 242), and 10 _ 1 
in those wdhout CAD (n = 66). p < 0.001. In patmnts ~ (~abeles and CAD 
(n = 37) the ACR was 64 ± 20, cotllpared to 22 ± 4,1 non-dklbe~cs 
CAD (n = 205), p = 0056. Se~ of CAD was related to ACR and insu(in: 
CAD Nag In = 645) I~k::l In = 131 MOd In = 70"1 Severe In = 1591 
ACR (rrg~g) 10 ~: 1 17 = 6 25 • 7" 31 ¢ 6" 
Ir'-c~u~n I~,U.'r~L) 13 : 1 12 ± I 15 ~ 2 24 ~ 4 "? 
Means ~. SE "p * 005vs nego~ r~ld: tp .  005v~ mad 
The odds ratvo (OR) for mcderate or severe CAD was 2.5 (95% C! 1.1-5.6, 
p < 0.05) in those with "mnary albumin >20 moJL: the OR was 2.9 (95% C| 
1.5,--5.9. p < 0.05) if insulin was also >16 .U/mL 
Conc/us/o~s: The presence of CAD and rts seventy is hvghly correlated 
with urinary albumin. The effect LS even greater in diabetes. MA~ with or 
without hyperinsulinemia, presets a high ask of clinK:ally s~gnificant CAD. 
[ • - •  Myocardial Perfusion Before Single and After 
Routine LDL-Apheres is  
C. Meyer. H.C. Geiss. C.S. Duvemov. K.G. ParhoteL P. S.Chw~Ln~U 
~? o~MWal~t: c~n~bnlT/l~i~tlS Of, ver'3;~ lLr'crfn~a/U~lversl~ M~ImCh. 
Germany 
Background: Lipid Iowenng therapy may improve corenaw vascular funcITon 
by a direct vascular effect of lipid concentration. 
Methods: We investigated the acute effect of a single LDL-apheresis 
(LDL-A) on myocardial pertusion by measuring myocardial bleed flow (MBF 
in ml/min/g) with N-13 ammonia/PET at rest and vasodilatory capacity dunng 
adenosine hyperemia (140 mg/koj'min for 5 rain,) in 10 patients (6 F/4 M) 
with heterozygous familial hypercholesterolemia (FH) and CAD treated with 
weekly LDL-A for 2-10 years. Patients were studied before and after LDL-A; 
each was randomly assigned to PET scan shortly before LDL-A and again 
one day later, or to PET scan just after LOL-A and again prior to LDL-A the 
following week. 
Results: see table. All values are mean ± SD 
The rate-pressure-product remained unchanged at rest and during adeno- 
sine. AlthouQh LDL-A induced a reduction of LDL-Cholesterol by 45%, pa- 
rameters of MBF remained unchanged. 
S(.an I ~n 2 p-v~e 
TotabChol 235 x 3,3 I~9 ~- 18 -0000001 
LOl=~hol 166 ~z 14 ~1~, x 9 ~000(~01 
M~F~,~ 0.88 • 0 31 0 79 ~: 020 ns 
MBF~mo=~e ~48 ~ 0~8 ~2t ~: 082 ns 
CFR ~§9± t 14 ~74 ±076 n~, 
has no instant 0ftect on myocardial r~rlku~n and vasoddatow r, ZK~IIy m 
pat~ w~n FH freat~ w~ wa~y kl~-^. 
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~ N ~ w  Therapeutic Poulb!llty for  ~ l s  A f t~ 
AngloplasW by Inhibit ing Pml l t~ l~/mMne 
~ho~/ l l l l lm of  Focal Adhe l lon  Klmme and 
PmlHlin 
K Miyosh~, V. Nozawa~ E Sasaki, H Terakawa. N Od l  Y Tanahasf,, 
Y. Yamasaki, Y. Murat~zka, H. Mh/aka, N. Ma~uur~L TattOo Ptmtmaoeutcal 
~ of smoom muscJe cegs (SMC) ceumng neomema ~ ~ 
known 1o be ( ~ .  on p~olefn-tyresine ~ (PTP) of focal 
TAS-30I, ,3~~Jmethy /ene-2~inone,  on FAK actlon m 
neomt~ma fonnalmn attar ~ mlmy In a rat balloon m~uly model, oral 
al~icalmfl of TAS-3OI s@11ficanfly reduced the number of Oa0s that migrated 
to llm lumen surface (at 100 m~,  50 ~ 5 (SD) ve. 95 :t: t5c~,  P < 
0.01) and the ratio of ml~ma ~ area ina d o ~  mlz, lx1~. 
In a modified Bo~n chamber a~aay, TAS-301 do~- ,x3~, -ay  intifll~ed 
ttte mKjratmn of rat Fg~lCinmspormetoPDGF.BB(at 3pM.65 ± 30,m 146 
± 14 ceg~4HPF, p < 0.01). Western blot ana~ with a n ~ n e  
antlt~,dy ~ that TAS..301 at 10 pM Inhd~led PTP of FAK (0.81 ± 0.12 
vs. 122 :~ 0.22-fold increase agaJnsl the control level, P < 0.05) and of 
ipaxillin (2.4 ¢ 0.7 vs. 4.4 ± 0.9, P < 0.01), ~ not that of PDGF-p r~or ,  
in rat SMC sllmulated by F~GF-BB. 
These data su~ that PTP of FAK and paxillin Ls a causally related to 
the migration phase of SMC du~ neo=r~ma formalin, n. and also s~gest 
ff~e r~w therapeubc poss~blltty ofTAS-301 for mslenosvs after angloplasty 
~ Function and Expression of 
Endofhelin~onverflng Enzyme-1 in Human 
Vascular Smooth Muscle 
F. Rusch~tzka, G. Nail. M. Lachat 1 , S. Sl~aw, "rE Lds~.dler. C ,a~,  
Can~iovascu/ar Research anal Institute Of Phy~,  Switzerland: Y C&dmc 
Surgery. University Zurich. S~tzedand 
Back~z:~:/: I~  ondothelin-1 (big ET-I) ~s coflverled to en~othattT~l by en- 
dotheltn co~wertmg enzymes OECE). previous sludies suggested that this 
conversion can be inhibited by the metalloprotease tnhll~for I~mi -  
don. 
Methods: Funct~ot~at ECE actnnty was studt~:l in isolated human arteries 
,/.,nZen~ I m~mmap,.P, .,;~,, ~ ~ ~,~'.~,t~p,,. P~ ~'ve~r~ ~,taw~mwe~, 
SV) in organ chambers. Express~on of ECE-1 was analyzed by RT-PCR in 
cultured smooth muscle cells. 
Results: Big ET-1 (1-100 nrnat/L) mo'ucad srmila~ contracllons in SV with 
(+E) or wdhout endothelium (-E) (+E: 62 ± !P/= of KCI; -E: 58 ± 7%; n = 
7), which were sK:jnificantly reduced (Out not prevented) by the ECE inhib,~or 
phospheramidon (0.1 mmol/L) (+E: 31 + 7%; -E" 27 ± 8%; p < 0,05 vs 
controls; +E./-E: n.s.), Big ET-I induced simdar responses in IMA (+E: 58 ± 
9%; -E: 51 :~ 9%: n = 7). In contrast, contractions were higher in RA (+E: 77 
± 9%; -E: 68 ± 10%: n = 7; p < 0.01 vs controls). While phosphommidon 
attenuated big ET-1 contractioP.s in IMA (+E: 40 ± 9%; -E: 38 ± lf%; p < 
0.05 vs controls), it did not affect responses in RA (+E: 79 ~ 8%; -E: 70 
+ 12%). ET-1 tissue content was significantly elevated in RA and IMA (p < 
0.001 vs SV). ECE-1 m.RNA could be detected in vascular smooth muscle 
cells of all arteries and veins investigated. 
Conclusions: These data demonstrate that (1) big ET-1 induces endethe- 
lium.indeper,~=mt contractions in human vessels and that (2) conversion of 
big ET-1 to ET-I is mediated by phosphoramidon-sensitive and insensitive 
~q.,%. -~Wlm-a~y :'n, -s'nlt.~ ~ -n~J~ ~:",~- '-Fi~'c~, " , "~ '~'~'~'~,~ `Y~&~'~=Cz~ 
